Propofol in Emergencies: Dosing, Risks, and Alternatives

Propofol is one of the most commonly used induction hypnotics in emergency medicine. Its rapid onset of action, short duration, and excellent controllability make it an attractive drug – both for Rapid Sequence Induction (RSI) and for procedural sedation. At the same time, propofol carries significant hemodynamic risks that can have fatal consequences in critically ill patients in the emergency setting. A thorough knowledge of the pharmacology, dosing regimens, and available alternatives is therefore essential for every emergency physician. This article provides a systematic overview of the evidence-based use of propofol in emergencies and clarifies when ketamine, etomidate, or midazolam represent the better choice.

Pharmacological Fundamentals

Mechanism of Action

Propofol (2,6-diisopropylphenol) acts primarily through potentiation of GABA-A receptor-mediated inhibition in the central nervous system. At higher concentrations, it also directly activates the GABA-A receptor. This results in:

• Sedation and hypnosis
• Anxiolysis
• Amnesia
• Anticonvulsive effects
• No analgesia

The lack of analgesic effect is a central point that is frequently underestimated in emergency medicine. For painful procedures or induction of anesthesia in trauma patients, an analgesic – typically an opioid – must always be added.

Pharmacokinetics

• Onset of action: 15–30 seconds after intravenous administration (one arm-brain circulation time)
• Clinical duration of action: 5–10 minutes after a single bolus
• Distribution half-life: 2–4 minutes (rapid redistribution to peripheral tissues)
• Elimination half-life: 4–7 hours (hepatic metabolism, extrahepatic clearance)
• Protein binding: approximately 97–99%
• Formulation: Lipid emulsion (soybean oil, egg lecithin, glycerol)

The rapid redistribution explains the short clinical duration of action after a single bolus. However, with repeated dosing or continuous infusion, saturation of the peripheral compartments occurs, leading to a significant prolongation of the context-sensitive half-life.

Dosing Regimens in the Emergency Setting

Rapid Sequence Induction (RSI)

The standard dose for induction of anesthesia in hemodynamically stable patients is:

• 1.5–2.5 mg/kg IV as a bolus over 20–30 seconds

Critical is the dose adjustment to the clinical condition:

Patient Group	Recommended Dose	Rationale
Healthy, hemodynamically stable	1.5–2.5 mg/kg	Standard dosing
Hemodynamically compromised	0.5–1.0 mg/kg (or alternative agent)	Pronounced vasodilation and cardiac depression
Elderly patients (> 65 years)	1.0–1.5 mg/kg	Reduced volume of distribution, increased sensitivity
Obese (BMI > 35)	Dose based on lean body weight	Lipophilicity causes prolonged effect when dosed by total body weight
Shock / Sepsis	Consider contraindication	Prefer alternatives such as ketamine

Practical tip: Especially in emergencies, it is advisable to administer the induction dose by titration – meaning to give 50–75% of the calculated dose initially and assess the effect after 30 seconds before administering the remaining dose. This approach significantly reduces the risk of severe hypotension.

Procedural Sedation

For procedural sedation – for example, cardioversion, joint reductions, or short painful procedures – propofol is used as titrated bolus doses:

• Initial bolus: 0.5–1.0 mg/kg IV
• Subsequent boluses: 0.25–0.5 mg/kg every 1–3 minutes as needed
• Target sedation depth: Moderate to deep sedation (Ramsay 4–5 or RASS −3 to −4)

Procedural sedation with propofol requires:

• Continuous SpO₂, ECG, and blood pressure monitoring
• Immediate availability of airway equipment (bag-valve mask, laryngeal mask airway, intubation supplies)
• At least one person dedicated exclusively to monitoring sedation and vital parameters
• Capnography (recommended, as it detects hypoventilation approximately 60 seconds before SpO₂ decline)

Sedation in Ventilated Patients

For continuous sedation of intubated patients in emergencies (e.g., transport ventilation):

• Infusion rate: 1–4 mg/kg/h IV
• Titration according to sedation scores (RASS, SAS)

Here, the Propofol Infusion Syndrome (PRIS) must be considered as a potentially lethal complication (see below), although it primarily occurs with prolonged infusion > 48 hours and high dosages.

Hemodynamic Risks

The hemodynamic side effects of propofol are the central point of criticism regarding its use in emergency medicine. Propofol causes blood pressure reduction through several mechanisms:

Mechanisms of Hypotension

1. Peripheral vasodilation: Reduction of systemic vascular resistance (SVR) by up to 15–40% through direct relaxation of vascular smooth muscle and inhibition of sympathetic vasoconstrictors.
2. Direct myocardial depression: Negative inotropy through effects on intracellular calcium homeostasis. The reduction in contractility can be 10–20%.
3. Vagotonic effects: Bradycardia, particularly in combination with opioids (fentanyl, sufentanil).
4. Reduction of preload: Venous pooling through venodilation.

Clinical Consequences

In hemodynamically stable patients, these effects are generally clinically manageable. However, in patients with the following conditions, propofol can trigger catastrophic circulatory decompensation:

• Hypovolemia (trauma, hemorrhage, dehydration)
• Septic shock (already maximized vasodilation)
• Cardiogenic shock (no compensatory reserve)
• Cardiac tamponade / tension pneumothorax (preload-dependent states)
• Severe aortic stenosis (fixed afterload, preload-dependent)
• Fixed heart rate (pacemaker, beta-blocker overdose)

The evidence-based literature shows that peri-intubation hypotension (PIH) is an independent predictor of increased mortality in critically ill patients. A blood pressure decrease of > 20% from baseline or a systolic blood pressure < 90 mmHg after induction of anesthesia is associated with significantly worse outcomes.

Risk Minimization

The following measures can reduce the risk of hypotension with propofol administration:

• Volume preloading: 250–500 mL crystalloid before induction (if clinically appropriate)
• Prepare push-dose vasopressors: Have phenylephrine (100 µg/mL) or epinephrine (10 µg/mL) drawn up in syringes and ready
• Norepinephrine infusion prepared: In patients with anticipated circulatory compromise, connect before induction
• Slow, titrated injection
• Dose reduction to 0.5–1.0 mg/kg in high-risk patients
• Or: Choose an alternative agent (see below)

Additional Risks and Complications

Respiratory Depression and Apnea

Propofol causes dose-dependent central respiratory depression up to apnea. This is desired during RSI but represents a relevant risk during procedural sedation. The combination with opioids potentiates this effect considerably.

Injection Pain

Injection pain with peripheral venous administration is a common problem (incidence 28–90% without prophylaxis). Proven countermeasures:

• Lidocaine 20–40 mg IV before propofol administration (or mixed in)
• Use of large-bore veins
• Rapid injection

Propofol Infusion Syndrome (PRIS)

PRIS is a rare but potentially lethal complication of prolonged propofol infusion (typically > 48 hours at > 4 mg/kg/h). Clinical features:

• Severe metabolic acidosis
• Rhabdomyolysis
• Hyperkalemia
• Acute kidney failure
• Cardiovascular collapse / Brugada-like ECG
• Lipemia

Although PRIS primarily occurs with prolonged sedation, it should be considered when taking over intensive care patients for emergency transport.

Allergies and Intolerances

The lipid emulsion contains egg lecithin and soybean oil. Relevant considerations:

• Soy/egg allergy: The evidence regarding cross-reactivity is not conclusive. In cases of known anaphylactic reaction to soy or egg, propofol should be avoided. A pure food intolerance is not considered an absolute contraindication based on current assessment.
• Lipid metabolism disorders: Relative contraindication in severe hypertriglyceridemia.

Contamination Risk

The lipid emulsion is an ideal bacterial growth medium. Opened propofol ampoules and syringes must be discarded after 6–12 hours (depending on manufacturer specifications). Aseptic technique is mandatory.

Alternatives to Propofol

Ketamine

Ketamine is the preferred alternative in many emergency medicine scenarios – and is increasingly regarded as the first-choice induction hypnotic in hemodynamically unstable patients.

Advantages over propofol:

• Sympathomimetic circulatory stability (increase in HR, BP, and SVR)
• Preservation of protective reflexes (relative)
• Bronchodilation
• Intrinsic analgesia
• Preservation of respiratory drive (at dissociative doses)

RSI dosing: 1.5–2.0 mg/kg IV Procedural sedation: 0.5–1.0 mg/kg IV (titrated)

Disadvantages:

• Sympathomimetic effects can paradoxically lead to circulatory decompensation in catecholamine-depleted patients (protracted shock) due to unmasked direct myocardial depression
• Psychomimetic side effects (emergence reactions): Prophylaxis with midazolam 1–2 mg or low-dose propofol
• Hypersalivation: Prophylaxis with glycopyrrolate or atropine possible
• Increase in intracranial pressure: According to current evidence, clinically not relevant with controlled ventilation

Preferred in: Hypotension, shock, bronchospasm, status asthmaticus, analgosedation in entrapped patients.

Etomidate

Etomidate was long considered the "standard induction hypnotic" for emergency anesthesia. It offers excellent hemodynamic stability with a predictable effect profile.

RSI dosing: 0.2–0.3 mg/kg IV Onset of action: 15–30 seconds Duration of action: 5–15 minutes

Advantages:

• Minimal circulatory effects
• Predictable onset of action
• No histamine release

Disadvantages:

• Adrenal suppression: Even a single bolus inhibits 11β-hydroxylase and thereby cortisol synthesis for 24–48 hours. The clinical relevance of this transient suppression is debated, but is potentially problematic particularly in septic patients.
• Myoclonus
• No analgesia
• Limited availability in Austria

Preferred in: Hemodynamically unstable patients when ketamine is not desired or is contraindicated, particularly in cardiac emergencies (acute coronary syndrome, heart failure).

Midazolam

Midazolam is no longer the first choice as a sole induction hypnotic for RSI, but is still used in combination (e.g., ketamine + midazolam) or for sedation.

RSI dosing: 0.1–0.3 mg/kg IV (unreliable onset, high interindividual variability) Procedural sedation: 0.02–0.05 mg/kg IV titrated

Disadvantages:

• Slow, unreliable onset of action
• High interindividual dose variability
• Blood pressure reduction (less than propofol, but clinically relevant)
• Long duration of action, poorly controllable

Advantage: Reversibility with flumazenil.

Comparison of Induction Hypnotics at a Glance

Parameter	Propofol	Ketamine	Etomidate	Midazolam
Induction dose (mg/kg)	1.5–2.5	1.5–2.0	0.2–0.3	0.1–0.3
Onset of action	15–30 s	30–60 s	15–30 s	60–90 s
Duration of action	5–10 min	10–20 min	5–15 min	15–30+ min
Hemodynamics	↓↓↓	↑ (sympathomimetic)	→ (stable)	↓
Respiratory depression	+++	+	++	++
Analgesia	−	+++	−	−
Anticonvulsive	+++	− (proconvulsive?)	+	+++
ICP effect	↓	→ (controversial)	→	↓

Clinical Decision Aid: When to Use Which Hypnotic?

The choice of induction hypnotic should primarily be guided by the hemodynamic status and the clinical situation of the patient:

• Hemodynamically stable, no special considerations: Propofol is a good choice – excellent controllability, rapid recovery.
• Hypotension, shock, hypovolemia: Prefer ketamine. Alternatively etomidate. Propofol only at significantly reduced doses and with vasopressors prepared.
• Status epilepticus: Propofol is an excellent option due to its anticonvulsive potency and good controllability (alternatively midazolam or thiopental).
• Acute coronary syndrome / cardiogenic shock: Etomidate or ketamine. Avoid propofol.
• Bronchospasm / status asthmaticus: Ketamine (bronchodilation) or propofol (moderate bronchodilation). Etomidate has no bronchodilatory properties.
• Sepsis: Prefer ketamine. Etomidate is controversial due to the adrenal insufficiency issue. Avoid propofol.
• Anaphylaxis: Ketamine (sympathomimetic, bronchodilatory). Propofol potentially problematic due to lipid emulsion (soy/egg).
• Elevated intracranial pressure: Propofol or midazolam (ICP-lowering). Ketamine is also acceptable according to current evidence with controlled ventilation.

Common Mistakes When Using Propofol in Emergencies

The following mistakes are regularly encountered in practice and are avoidable:

1. No dose adjustment in shock: The "standard textbook dose" of 2 mg/kg is given without consideration, even though the patient is already hypotensive.
2. No vasopressor preparation: Push-dose pressors and/or norepinephrine infusion are not drawn up when hypotension occurs.
3. No supplemental analgesia: Propofol is used as the sole medication for painful procedures.
4. Procedural sedation without adequate monitoring: Missing capnography, no airway readiness.
5. Neglect of preload optimization: No fluid bolus before induction in dehydrated or bleeding patients.
6. Too rapid bolus injection: Injection over < 10 seconds leads to higher peak levels and more pronounced hypotension than slow administration over 20–30 seconds.

Practical Training

The safe use of propofol and knowledge of its alternatives require far more than theoretical knowledge. The critical decision moments – dose adjustment in unstable hemodynamics, rapid switching to an alternative induction hypnotic, management of peri-intubation hypotension – are best trained in realistic simulation scenarios. In the ACLS courses offered by Simulation Tirol, you practice these situations under realistic conditions, receive structured feedback, and deepen your pharmacological knowledge through concrete case examples. This way, you are prepared to use the right agent at the right dose at the right time when it truly matters.